Literature DB >> 28226362

Ambulatory Arterial Stiffness Indexes in Cushing's Syndrome.

Marialberta Battocchio1, Andrea Rebellato1, Andrea Grillo2, Francesca Dassie1, Pietro Maffei1, Stella Bernardi2, Bruno Fabris2, Renzo Carretta2, Francesco Fallo1.   

Abstract

Long-standing exposure to endogenous cortisol excess is associated with high cardiovascular risk. The aim of our study was to investigate arterial stiffness, which has been recognized as an independent predictor of adverse cardiovascular outcome, in a group of patients with Cushing's syndrome. Twenty-four patients with Cushing's syndrome (3 males, mean age 49±13 years; 20 pituitary-dependent Cushing's disease and 4 adrenal adenoma) underwent 24-h ambulatory blood pressure monitoring (ABPM) and evaluation of cardiovascular risk factors. The Ambulatory Arterial Stiffness Index (AASI) and symmetric AASI (sAASI) were derived from ABPM tracings. Cushing patients were divided into 8 normotensive (NOR-CUSH) and 16 hypertensive (HYP-CUSH) patients, and were compared with 8 normotensive (NOR-CTR) and 16 hypertensive (HYP-CTR) control subjects, matched for demographic characteristics, 24-h ABPM and cardiometabolic risk factors. The AASI and sAASI indexes were significantly higher in Cushing patients than in controls, either in the normotensive (p=0.048 for AASI and p=0.013 for sAASI) or in the hypertensive (p=0.004 for AASI and p=0.046 for sAASI) group. No difference in metabolic parameters was observed between NOR-CUSH and NOR-CTR or between HYP-CUSH and HYP-CTR groups. AASI and sAASI were both correlated with urinary cortisol in patients with endogenous hypercortisolism (Spearman's rho=0.40, p=0.05, and 0.61, p=0.003, respectively), while no correlation was found in controls. Both AASI and sAASI are increased in Cushing syndrome, independent of BP elevation, and may represent an additional cardiovascular risk factor in this disease. The role of excess cortisol in arterial stiffness has to be further clarified. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28226362     DOI: 10.1055/s-0043-100385

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  3 in total

1.  Long-term magnesium supplementation improves glucocorticoid metabolism: A post-hoc analysis of an intervention trial.

Authors:  Joëlle C Schutten; Peter J Joris; Isidor Minović; Adrian Post; André P van Beek; Martin H de Borst; Ronald P Mensink; Stephan J L Bakker
Journal:  Clin Endocrinol (Oxf)       Date:  2020-10-26       Impact factor: 3.478

2.  Genome-wide association study of hyperthyroidism based on electronic medical record from Taiwan.

Authors:  Ting-Yuan Liu; Wen-Ling Liao; Tzu-Yuan Wang; Chia-Jung Chan; Jan-Gowth Chang; Yu-Chia Chen; Hsing-Fang Lu; Hsien-Hui Yang; Shih-Yin Chen; Fuu-Jen Tsai
Journal:  Front Med (Lausanne)       Date:  2022-07-27

3.  Changes in systolic blood pressure in dogs with pituitary dependent hyperadrenocorticism during the first year of trilostane treatment.

Authors:  Paula García San José; Carolina Arenas Bermejo; Daniel Alonso-Miguel; Irene Clares Moral; Pedro Cuesta-Alvaro; María Dolores Pérez Alenza
Journal:  J Vet Intern Med       Date:  2020-12-04       Impact factor: 3.175

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.